Literature DB >> 7895163

The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo.

L Huang1, G Soldevila, M Leeker, R Flavell, I N Crispe.   

Abstract

Deletion of mature peripheral T cells may result from TCR ligation by bacterial enterotoxins, endogenous provirus-encoded superantigens, and peptide antigens. But the ultimate fate of deleted T cells is not clear. Using a line of T cell receptor transgenic mice injected with antigenic peptide, we have documented that peripheral deletion is accompanied by the induction of abortive T cell activation followed by the disappearance of transgene-positive T cells. As these T cells disappear from the lymph nodes and spleen, they accumulate in the liver, where they undergo apoptosis. This is likely to be a general clearance pathway for T cells that are programmed to undergo apoptosis in vivo, and it may further explain the expansion of the intrahepatic T cell pool in mice with genetic defects in the T cell apoptosis mechanism, such as the lpr mutant.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7895163     DOI: 10.1016/s1074-7613(94)80016-2

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  74 in total

Review 1.  Death and destruction of activated T lymphocytes.

Authors:  I N Crispe
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 2.  The role of CD4 in regulating homeostasis of T helper cells.

Authors:  Rolf König; Xiaoli Shen; Rosario Maroto; Timothy L Denning
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

3.  Apoptosis-inducing protein derived from hepatocyte selectively induces apoptosis in lymphocytes.

Authors:  Masanobu Ikeda; Hideshi Yoshikawa; Jie Liu; Yasuo Nakajima; Yoshihiro Akahane; Kachio Tasaka
Journal:  Immunology       Date:  2003-01       Impact factor: 7.397

4.  Innate and acquired immunity intersect in a global view of the acute-phase response.

Authors:  Joo-Yeon Yoo; Stephen Desiderio
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-22       Impact factor: 11.205

5.  Peripheral immunization induces functional intrahepatic hepatitis C specific immunity following selective retention of vaccine-specific CD8 T cells by the liver.

Authors:  Krystle A Lang Kuhs; Roberta Toporovski; Arielle A Ginsberg; Abby L Olsen; Devon J Shedlock; Matthew P Morrow; Jian Yan; Rebecca G Wells; David B Weiner
Journal:  Hum Vaccin       Date:  2011-12-01

6.  Tissue exit: a novel control point in the accumulation of antigen-specific CD8 T cells in the influenza a virus-infected lung.

Authors:  Silke Jennrich; Michael H Lee; Rachel C Lynn; Kristofer Dewberry; Gudrun F Debes
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

7.  Increased ribonuclease expression reduces inflammation and prolongs survival in TLR7 transgenic mice.

Authors:  Xizhang Sun; Alice Wiedeman; Nalini Agrawal; Thomas H Teal; Lena Tanaka; Kelly L Hudkins; Charles E Alpers; Silvia Bolland; Matthew B Buechler; Jessica A Hamerman; Jeffrey A Ledbetter; Denny Liggitt; Keith B Elkon
Journal:  J Immunol       Date:  2013-02-04       Impact factor: 5.422

8.  Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: implications for immunotherapy of persistent viral infections.

Authors:  Kazuhiro Kakimi; Masanori Isogawa; JoSan Chung; Alessandro Sette; Francis V Chisari
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 9.  Mechanisms of drug-induced liver injury.

Authors:  Michael P Holt; Cynthia Ju
Journal:  AAPS J       Date:  2006-02-03       Impact factor: 4.009

10.  Impaired hepatitis C virus (HCV)-specific effector CD8+ T cells undergo massive apoptosis in the peripheral blood during acute HCV infection and in the liver during the chronic phase of infection.

Authors:  Henry Radziewicz; Chris C Ibegbu; Huiming Hon; Melissa K Osborn; Kamil Obideen; Mohammad Wehbi; Gordon J Freeman; Jeffrey L Lennox; Kimberly A Workowski; Holly L Hanson; Arash Grakoui
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.